Inhibikase Therapeutics Ownership & Insider Activity

Inhibikase Therapeutics (IKT) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.3% of shares outstanding. Institutional investors hold 19.1%.

Shares Outstanding

139.536M

Shares Float

89.604M

Insider Shares Owned

6.786M

Insider % Owned

4.3%

Institutional Shares Held

26.630M

Institutional % Held

19.1%

Ownership Breakdown

Net Insider Activity by Month

Inhibikase Therapeutics Insider Transactions (Last 6 Months)

No insider filings in the last 6 months.